Research progress in gastrointestinal transportation of cyclodextrin inclusion complex and its mechanism

( views:513, downloads:0 )
Author:
XU Xiao-yan()
YUN Fei()
DI Liu-qing()
ZHAO Xiao-li()
BI Xiao-lin()
SHAN Jin-jun()
KANG An()
Journal Title:
Chinese Traditional and Herbal Drugs
Issue:
Volume 43, Issue 10, 2012
DOI:
Key Word:

Abstract:

  • [1]吴 霖,俞 英.环糊精超分子包结物的制备与应用前景[J].江苏化工,2003,31(2):32-35.
  • [2]荣立新,孙 晖,王克君,等.环糊精在药剂学上的应用[J].中国药学杂志,2000,35(10):709-710.
  • [3]张卫敏,任晓文,徐为人,等.分子模拟技术在释药技术中的应用[J].药物评价研究,2012,35(2):86-89.
  • [4]Westerberg G,Wiklund L.Beta-cyclodextrin reduces bioavailability of orally administered[H-3]benzo[a]pyrene in the rat[J].JPharm Sci,2005,94(1):114-119.
  • [5]蒋 晔,沙先谊,张 伟,等.9-硝基喜树碱羟丙基-β-环糊精冻干粉针剂的研究[A].2010年中国药学大会暨第十届中国药师周,2010年中国药学大会暨第十届中国药师周论文集[C].北京:中国药学会,2010.
  • [6]廖昌军,曹丽萍,高秀蓉,等.葛根素β-环糊精包合物小鼠血浆中生物利用度研究[J].四川生理科学杂志,2009,31(2):64-66.
  • [7]肖 莉,翟所迪,赵荣生.水飞蓟素羟丙基-β-环糊精包合物在大鼠体内的生物利用度[J].中国医院药学杂志,2006,26(2):140-142.
  • [8]Shulman M,Cohen M,Soto-Gutierrez A,et al.Enhancement of naringenin bioavailability by complexation with hydroxypropoyl-β-cyclodextrin[J].Plos One,2011,6(4):e18033.
  • [9]苏柘僮,杨 明,吴品江,等.胆酸-羟丙基-β-环糊精包合物的物相鉴别及体外鼻黏膜渗透评价[J].中草药,2009,40(6):878-882.
  • [10]Freedman K A,Klein J W,Crosson C E.Betacyclodextrins enhance bioavailability of pilocarpine[J].CurrEyeRes,1993,12(7):641-647.
  • [11]Panini R,Vandelli M A,Forni F,et al.Improvement of ursodeoxycholic acid bioavailability by 2-hydroxypropylbeta-cyclodextrin complexation in healthy volunteers[J].Pharmacol Res,1995,31(3/4):205-209.
  • [12]Tokumura T,Nanba M,Tsushima Y,et al.Enhancement of bioavailability of cinnarizine from its beta-cyclodextrin complex on oral administration with DL-phenylalanine as a competing agent[J].JPharm Sci,1986,75(4):391-394.
  • [13]江再茂,刘受猛.β-环糊精包合物增加氢氯噻嗪溶解度和溶出度的实验[J].中华临床医药杂志,2003,64:113-114.
  • [14]宋洪涛,郭 涛,张跃新,等.2-羟丙基-p-环糊精对大蒜油溶解度及稳定性的影响[J].中草药,2006,37(2):199-202.
  • [15]王亚静,高文远.相溶解度法研究羟丙基-β-环糊精对黄芪甲苷的增溶效果[J].中草药,2007,38(5):710-711.
  • [16]金燕,吉翔,刘永琼,等.维生素E-β-环糊精包合物溶出度研究及Weibull模型分析[J].数理医药学杂志,2010,23(3):344-347.
  • [17]张叶,崔元璐,田俊生,等.淫羊藿苷/β-环糊精包合物的表征及体外溶出研究[J].辽宁中医杂志,2009,36(3):428-431.
  • [18]Loftsson T,Brewster M E.Pharmaceutical applications of cyclodextrins: effects on drug permeation through biological membranes[J].J Pharm Pharmacol,2011,63(9):1119-1135.
  • [19]Brewster M E,Noppe M,Peeters J,et al.Effect of the unstirred water layer on permeability enhancement by hydrophilic cyclodextrins [J].Int J Pharm, 2007,342(1/2):250-253.
  • [20]Loftsson T,Konrá(o)sdóttir F,Másson M.Influence of aqueous diffusion layer on passive drug diffusion from aqueous cyclodextrin solutions through biological membranes[J].Pharmazie,2006,61(2):83-89.
  • [21]Arima H,Yunomae K,Morikawa T,et al.Contribution of cholesterol and phospholipids to inhibitory effect of dimethyl-beta-cyclodextrin on efflux function of P-glycoprotein and multidrug resistance-associated protein 2 in vinblastine-resistant Caco-2 cell monolayers[J].Pharm Res,2004,21(4):625-634.
  • [22]Modok S,Heyward C,Callaghan R.P-glycoprotein retains function when reconstituted into a sphingolipid and cholesterol-rich environment[J].J Lipid Res,2004,45(10):1910-1918.
  • [23]Fenyvesi F,Fenyvesi E,Szente L,et al.P-glycoprotein inhibition by membrane cholesterol modulation[J].Eur J Pharm Sci,2008,34(4/5):236-242.
  • [24]Yunomae K,Arima H,Hirayama F,et al.Involvement of cholesterol in the inhibitory effect of dimethyl-β-cyelodextrin on P-glycoprotein and MRP2 function in Caco-2 cells[J].FEBS Lett,2003,536(1/3):225-231.
  • [25]张艳斌,崔元璐.环糊精包合作用对在体大鼠肠道P-糖蛋白药泵的影响[J].中国药理学通报,2008,24(10):1318-1323.
  • [26]Arima H,Yunomae K,Hirayama F,et al.Contribution of P-glycoprotein to the enhancing effects of dimethyl-beta-cyclodextrin on oral bioavailability of tacrolimus[J].J Pharmacol Experl Therap,2001,297(2):547-555.
  • [27]Doi N,Tomita M,Hayashi M.Absorption enhancement effect of acylcarnitines through changes in tight junction protein in Caco-2 cell monolayers[J].Drug Metab Pharm,2011,26(2):162-170.
  • [28]Sajeesh S,Bouchemal K,Marsaud V,et al.Cyclodextrin complexed insulin encapsulated hydrogel microparticles:An oral delivery system for insulin[J].J Controlled Release,2010,147(3):377-384.
  • [29]Loftsson T,Masson M.Cyclodextrins in topical drug formulations:theory and practice[J].Int J Pharm,2001,225(1/2):15-30.
  • [30]Matsuda H,Arima H.Cyelodextrins in transdermal and rectal delivery[J].Adv Drug Deliv Rev,1999,36(1):81-99.
  • [31]Tanaka M,Iwata Y,Kouzuki Y,et al.Effect of 2-hydroxypropyl-β-cyclodextrin on pereutaneous absorption of methyl paraben[J].J Pharm Pharmacol,1995,47(11):897-900.
  • [32]Uekama K,Arimori K,Sakai A,et al.Improvement of percutaneous absorption of prednisolone by β-and γ-cyclodextrin complexations[J].Chem Pharm Bull,1987,35(7):2910-2913.
  • [33]Uekama K,Hirayama F,Irie T.Cyclodextrin drug carrier systems[J].Chem Rev,1998,98(5):2045-2076.
  • [34]Loftsson T, Duchene D. Cyclodextrins and their pharmaceutical applications[J].lnt J Pharm,2007,329(1/2):1-11.
  • [35]Loftsson T,Hreinsdottir D,Masson M.Evaluation of cyclodextrin solubilization of drugs[J].Int J Pharm,2005,302(1/2):18-28.
  • [36]Loftsson T,Vogensen S B,Brewster M E,et al.Effects of cyclodextrins on drug delivery through biological membranes[J].JPharm Sci,2007,96(10):2532-2546.
  • [37]Kissa T,Fenyvesi F,Bácskaya I,et al.Evaluation of the cytotoxicity of β-cyclodextrin derivatives:Evidence for the role of cholesterol extraction[J].Eur J Pharm Sci,2010,40(4):376-380.
  • [38]Motoyama K,Arima H,Toyodome H,et al.Effect of 2,6-di-O-methyl-β-cyclodextrin on hemolysis and morphological change in rabbit's red blood cells[J].Eur J Pharm Sci,2006,29(2):111-119.
  • [39]杨郁,张国梅,双少敏,等.环糊精包合作用及其分子识别功能的研究进展[J].光谱实验室,2003,20(2):169-180.
  • [40]周冬香,孙涛,邓维.环糊精相关的超分子自组装最新进展[J].有机化学,2012,32:239-253.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn